Form 8-K Werewolf Therapeutics, For: Aug 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St inches lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil slides on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
- Ovintiv adds 41,000 acres in Permian and Montney deals
Werewolf Therapeutics sells platform assets to EMD Serono for $33M
August 20, 2026 4:12 PM EDTWerewolf Therapeutics (NASDAQ: HOWL) sold its pre-clinical INDUCER platform and portions of its INDUKINE platform to EMD Serono Research & Development Institute Inc. on Aug. 14, 2026, under an asset purchase agreement.
Under the terms of the agreement, EMD Serono agreed to pay $28.0 million upfront, with... More
